Your Sorted CME/CE Activities

Quarterly Brief (October-December, 2022): A Current Expert Analysis on Important HIV Clinical Decisions
AMA/ANCC/ACPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from October through December of 2022 will discuss the most clinically relevant information regarding Long-Acting ART, General ART Studies, Cancer and Coinfections and Mpox and HIV.

Review the Full Program or segment of interest. Claim up to 0.5 AMA, ANCC, or ACPE credit/contact hour(s) after completion of a brief post-test/evaluation.

Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Darcy Wooten, MD, MS Darcy Wooten, MD, MS
Associate Professor of Medicine
Program Director, UCSD ID Fellowship Training Program
Clinical Foundations Co-Director, UCSD School of Medicine
UCSD Division of Infectious Diseases and Global Public Health

Supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Launch Date: January 25, 2023
Release Date: January 25, 2023
Expiration Date: December 31, 2023

December 31, 2023
Mini Module